Diagnose on
DAYZERO

Same Day ID and AST from Clinical Samples Without Culture

Featured NEWS

Day Zero Diagnostics Presents at 2024 ASM Microbe Conference
DZD Presents Direct-From-Blood, Rapid Antimicrobial Susceptibility Testing
Read More
Oxford Nanopore and DZD Partnership
Collaboration aimed at optimizing a same-day identification diagnostic system for clinical use.
Read More
DZD Names Jeff Mirviss Chair of Board of Directors
"Jeff has been an important advisor, investor and supporter of DZD... the company has benefitted greatly from his involvement and counsel."
Read More

Public Health Crisis

Antibiotic resistance is an ongoing crisis that causes at least 700,000 global deaths annually. By 2050, this figure is expected to grow to 10 million. Patients can die of a severe infection like sepsis within hours, but current diagnostics for antibiotic resistance can take 2-5 days or never return a result at all. Physicians are left to treat using trial and error approaches based on limited information – the exact opposite of precision medicine.

Learn More

Infectious Disease Diagnostics

DZD is developing rapid, whole genome sequencing-based diagnostics to modernize infectious disease diagnosis and treatment.

We are changing the standard of care by delivering the “Holy Grail” of infectious disease diagnostics – rapid, full spectrum organism identification (ID) and antimicrobial resistance and susceptibility (AMR/S) profiling in hours rather than days. Our mission is to empower physicians in the hospital with the information they need to confidently practice precision medicine on patients with a life-threatening infection, rather than “carpet bombing” them with overly broad and toxic therapies that can still be ineffective in a world of multiple drug resistant organisms.

View Our Work

Rapid Response Partner

DZD is also developing technologies to help control HAIs (healthcare-associated infections), where antibiotic resistant organisms can be especially dangerous. Our rapid turnaround epiXact® service uses whole genome sequencing to provide infection control professionals with precise information on pathogen relatedness in less than 2 days, so they can make the right intervention decisions early and confidently.

Learn More